Search Results 1701-1710 of 110097 for b-

  1. Faculty - Cardiovascular Research Center - Mayo Clinic Research

    b · Best, Patricia J M M.D.. best.patricia@mayo.edu; Associate Professor of Medicine · Borlaug, Barry A. M.D. · borlaug.barry@mayo.edu; Professor of Medicine ...

  2. Chemotherapy nausea and vomiting: Prevention is best defense - Mayo Clinic

    B-cell lymphoma · Biliary tract cancer: Should I get a second opinion? Biopsy ... Curcumin: Can it slow cancer growth? Cutaneous B-cell lymphoma.

  3. Publications - Isabel O. Cortopassi, M.D. - Mayo Clinic

    Cortopassi IO, Gosangi B, Asch D, Bader AS, Gange CP, Rubinowitz AN. Diseases of the pulmonary arteries: imaging appearances and pearls. Clin Imaging. 2022 ...

  4. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    Hepatitis B or C serologic status: Hepatitis B surface antigen and hepatitis B PCR positive will be excluded; Hepatitis B core antibody (anti-HBc) positive ...

  5. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

    Participation eligibility · Subjects who are hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative will need to have a negative ...

  6. Faculty - Division of Gastroenterology and Hepatology - Mayo Clinic Research

    B · Bamidele, Wale O. Ph. · Beyder, Arthur M.D., Ph.D. · Bharucha, Adil E. M.B.B.S., M.D. · bharucha.adil@mayo.edu · Bi, Yan M.D., Ph.D. · Boardman, Lisa A. M.D..

  7. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    About this study. The primary purpose of Parts A and B of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of BIIB067 in adults ...

  8. Publications - Joseph Y. Cheung, M.D. - Mayo Clinic

    Neshat SS, Heidari A, Henriquez-Beltran M, Patel K, Colaco B, Arunthari V, Lee Mateus AY, Cheung J, Labarca G. Evaluating pharmacological treatments for ...

  9. Waldenstrom Macroglobulinemia Clinical Trials - Mayo Clinic Research

    ... B cell non-Hodgkin lymphoma (B-NHL), chronic lymphocytic leukemia (CLL) or Waldenstrom's macroglobulinemia (WM). Study of the Glutaminase Inhibitor CB-839 ...

  10. Breast cancer - Doctors and departments - Mayo Clinic

    May Elbanna, M.B., B.Ch., Ph.D. Radiation Oncologist. Rochester, MN. Areas of focus: Radiation therapy, Proton therapy ...